Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
Dai ChiharaJason R WestinRoberto N MirandaChan Y CheahYasuhiro OkiFrancesco TurturroJorge E RomagueraSattva S NeelapuLorreta J NastoupilLuis E FayadM Alma RodriguezNathan H FowlerRobert Z OrlowskiMichael WangFredrick B HagemeisterL Jeffrey MedeirosMichelle A FanalePublished in: British journal of haematology (2016)